• The collaboration combines Werfen’s validated transplant assays with Oxford Nanopore’s sequencing technology to deliver fast, high-resolution results, essential for precise donor-recipient matching. • The collaboration streamlines and provides validated “sample-to-answer” workflows, making advanced assays more accessible to laboratories worldwide.
A novel single-cell multiomics platform developed at the Sylvester Comprehensive Cancer Center simultaneously quantifies intracellular proteins and transcriptomes, overcoming a longstanding limitation of RNA-based immune profiling. By capturing RNA, surface proteins, intracellular cytokines, and multiplexing data in one workflow, CIPHER-seq delivers a five-layer picture of immune activation with markedly reduced cellular stress artefacts – offering […]
A compound derived from the notorious nitazene class of synthetic opioids has demonstrated powerful analgesic properties in rodent models whilst avoiding the cardinal adverse effects – respiratory depression, tolerance, dependence, and addiction – that have long been considered inseparable from high-efficacy muopioid receptor agonism. The findings, published in Nature, may fundamentally alter the pharmacological framework […]
A nanophotonic biochip paired with deep-learning image analysis can identify multiple microRNA biomarkers with attomolar sensitivity and greater than 99% accuracy – without amplification or enrichment steps. Developed by researchers at Nanyang Technological University, Singapore, the platform detected three lung cancer-associated miRNAs directly from cell extracts in under 20 minutes, which could change how clinicians […]
A new collaboration between FUJIFILM Biosciences and Ottawa-based Virica Biotech aims to address one of the most persistent constraints in gene therapy manufacturing: the cost-effective, large-scale production of adeno-associated virus (AAV) vectors. The partnership, announced on 8 April 2026, is supported by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) under […]
Thermo Fisher Scientific has opened a 70,000 sq.ft. distribution centre in Bracetown, County Meath, Ireland, boosting the company’s in-country capacity by more than 400%. The purpose-built site is designed to service Ireland’s pharmaceutical and biopharmaceutical sector, providing improved access to critical materials, chemicals and temperature-sensitive products for drug discovery, clinical development and commercial manufacturing operations.
Atelerix, the Newcastle-based biotech company specialising in non-cryogenic biological preservation, has announced a strategic partnership with JH Health Ltd, a Saudi Arabian medical and health technology company, granting JH Health exclusive rights to use and distribute Atelerix’s hydrogel-based cell and tissue preservation solutions across the Middle East.
The Society of Laboratory Automation and Screening (SLAS) has announced the 12 emerging life science companies selected to participate in its Innovation AveNEW programme at SLAS Europe 2026, to be held in Vienna, Austria from 19 to 21 May 2026. The cohort spans six countries and represents a broad range of enabling technologies across laboratory […]
Lonza opens Singapore media development lab to de-risk biomanufacturing scale-up Lonza, one of the world’s leading contract development and manufacturing organisations (CDMOs), has launched a dedicated Media Development Lab at its Singapore facility, offering bioprocessing clients a structured service to optimise cell culture media formulations ahead of GMP manufacturing.
Sakura Finetek, the automated tissue and slide preparation specialist, has entered into a global strategic partnership with Hamamatsu Photonics K.K. to create an integrated end-to-end digital pathology workflow spanning slide preparation through to whole slide imaging (WSI). The alliance aims to reduce pre-analytical variability and rework by aligning consistently prepared histology slides with reliable high-throughput […]
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
